TW200642681A - Medical composition for treating respiratory allergic disease - Google Patents

Medical composition for treating respiratory allergic disease

Info

Publication number
TW200642681A
TW200642681A TW094119802A TW94119802A TW200642681A TW 200642681 A TW200642681 A TW 200642681A TW 094119802 A TW094119802 A TW 094119802A TW 94119802 A TW94119802 A TW 94119802A TW 200642681 A TW200642681 A TW 200642681A
Authority
TW
Taiwan
Prior art keywords
medical composition
allergic disease
treating respiratory
respiratory allergic
inflammation
Prior art date
Application number
TW094119802A
Other languages
Chinese (zh)
Other versions
TWI281859B (en
Inventor
Wen-Mein Wu
Shin-Miao Hou
Bor-Luen Chiang
Original Assignee
Univ Fu Jen Catholic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Fu Jen Catholic filed Critical Univ Fu Jen Catholic
Priority to TW94119802A priority Critical patent/TWI281859B/en
Publication of TW200642681A publication Critical patent/TW200642681A/en
Application granted granted Critical
Publication of TWI281859B publication Critical patent/TWI281859B/en

Links

Abstract

The present invention provides a medical composition for treating respiratory allergic disease. An active ingredient of the medical composition comprises caffeic acid phenethyl ester (CAPE) improving conditions of respiratory inflammation syndrome by its anti-inflammation effect.
TW94119802A 2005-06-15 2005-06-15 Medical composition for treating respiratory allergic disease TWI281859B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW94119802A TWI281859B (en) 2005-06-15 2005-06-15 Medical composition for treating respiratory allergic disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW94119802A TWI281859B (en) 2005-06-15 2005-06-15 Medical composition for treating respiratory allergic disease

Publications (2)

Publication Number Publication Date
TW200642681A true TW200642681A (en) 2006-12-16
TWI281859B TWI281859B (en) 2007-06-01

Family

ID=38777544

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94119802A TWI281859B (en) 2005-06-15 2005-06-15 Medical composition for treating respiratory allergic disease

Country Status (1)

Country Link
TW (1) TWI281859B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114524874A (en) * 2022-03-04 2022-05-24 广东医科大学 Method for reducing ovalbumin allergy by laccase/caffeic acid crosslinking and galactomannan combination

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114524874A (en) * 2022-03-04 2022-05-24 广东医科大学 Method for reducing ovalbumin allergy by laccase/caffeic acid crosslinking and galactomannan combination
CN114524874B (en) * 2022-03-04 2023-08-11 广东医科大学 Laccase/caffeic acid cross-linking and galactomannan combined method for reducing ovalbumin allergy

Also Published As

Publication number Publication date
TWI281859B (en) 2007-06-01

Similar Documents

Publication Publication Date Title
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
ATE417610T1 (en) COMPOSITION CONTAINING 6-Ä3-(1-ADAMANTYL)-4-METHOXYPHENYLÜ-2-NAPHTHANOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISEASES
MX366175B (en) Concentrated therapeutic phospholipid compositions.
IN2012DN00639A (en)
IL195030A (en) Dpp iv inhibitor formulations
ATE495743T1 (en) TRIAZOLOPYRIDINE COMPOUNDS FOR THE TREATMENT OF DEGENERATIONAL AND INFLAMMATORY DISEASES
MX2012012225A (en) Nitric oxide releasing prodrugs of therapeutic agents.
UA110013C2 (en) APPLICATION OF THE COMPOSITION FOR THE TREATMENT OF BALL-MARI-HERE AND THE RELATED DISORDERS
WO2009111700A3 (en) Oxadiazoanthracene compounds for the treatment of diabetes
AU2007257423A8 (en) Purine analogs
CY1113449T1 (en) ANTI-VISUAL COMPOSITIONS CONTAINING GERANIOL AND CARBON
JO2973B1 (en) Fumarate Salt Of (alphaS, betaR)-6-Bromo-alfa-[2-(dimethylamino)ethyl]-2- Methoxy-alpha-1-naphthalenyl-beta-phenyl-3- Quinolineethanol
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
BR112013026257A2 (en) glycoside derivatives and uses thereof for the treatment of diabetes
WO2012006298A3 (en) Formulation for co-therapy treatment of diabetes
SG178975A1 (en) Indenone derivative and pharmaceutical composition comprising same
EP2361083A4 (en) Composition for treatment of epithelial tissue
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
EA201270747A1 (en) COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF THE RAS
MX2013002649A (en) Therapeutic agent for pain.
EA201070898A1 (en) NEW HINAZOLIN-2,4-DIONA DERIVATIVE AND MEDICINAL COMPOSITIONS ON ITS BASIS FOR PREVENTION AND TREATMENT OF THE DISEASE, CAUSED BY DAMAGE OF THE CRANIAL NERVE
TW200642681A (en) Medical composition for treating respiratory allergic disease
MX2009006212A (en) Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component.
HN2007000505A (en) PIRAZOL ANALOGS
BR112013000296A2 (en) therapeutic agents 976

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees